Vaccines
The possibility to develop and to use vaccines has revolutionized the history of mankind health care. With the use of vaccines, the society got the ability to improve everyman health and to save lives. Vaccination can be a tool of controlling, elimination, or near-elimination of many life-threatening diseases.
Today, vaccines can be defined as biological preparation containing attenuated or killed pathogens or any other component, including peptides, proteins DNA, mRNA or polysaccharides, which upon injection, may help to prevent an individual from any possible future infection.
We at ARTES transfer microbial cell lines and processes for VLP-based vaccines. Our customers have achieved for various vaccines successful clinical trials at EMA and US-FDA.
The VLP production processes we are offering result in highly immunogenic vaccines with cost of goods of significantly less than 1 Euro per dose.
All listed cell lines are based on our safe and high yield yeast expression system Hansenula polymorpha.
| ready for transfer | |||
|---|---|---|---|
| Product | Manufactured in | Marketed in / Licensed to: | Deliverables |
| Hepatitis B | yeast | India, Indonesia, Thailand, USA | RCB (pre-MCB) USP, DSP, IPC/QC |
| Human Papilloma Virus (HPV) (L1-6; -11; -16; -18) | yeast | India, Indonesia, Thailand, USA | RCB (pre-MCB) USP, DSP, IPC/QC |
| Under development | |
|---|---|
| Product | Manufactured in: |
| Avian Flu | yeast |
| Hepatitis E | yeast |
| Lyme | E. coli |
| Malaria | yeast |
| West Nile Virus (WNV) | yeast |
To obtain a quote, please contact us at info(at)artes-biotechnology.com indicating name of the vaccine of interest to you. We will revert to you with a dedicated offer specifying delivery times and cost.